Rocket Pharmaceuticals (RCKT) Free Cash Flow (2014 - 2026)
Rocket Pharmaceuticals (RCKT) reported Free Cash Flow of -$45.5 million for Q1 2026, up 18.54% on a YoY basis from -$38.4 million in Q1 2025, and down 30.26% sequentially from -$34.9 million in Q4 2025.
Rocket Pharmaceuticals (RCKT) Free Cash Flow (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 13 years of Free Cash Flow data on file, last reported at -$45.5 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 18.54% year-over-year to -$45.5 million; the trailing twelve-month figure through Mar 2026 stood at -$180.1 million (up 15.26% YoY), and the FY2025 full-year result was -$190.5 million, up 11.66% from the prior year.
- Free Cash Flow fell to -$45.5 million in Q1 2026, from -$34.9 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$34.9 million in Q4 2025 to a low of -$59.4 million in Q1 2023.
- A 5-year average of -$49.6 million and a median of -$50.3 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow plunged 67.32% in 2022 and surged 33.54% in 2025, its largest moves.
- Tracing RCKT's Free Cash Flow over 5 years: stood at -$52.8 million in 2022, then gained by 16.41% to -$44.1 million in 2023, then dropped by 19.12% to -$52.5 million in 2024, then surged by 33.54% to -$34.9 million in 2025, then slumped by 30.26% to -$45.5 million in 2026.
- Business Quant data shows RCKT's Free Cash Flow at -$45.5 million in Q1 2026, -$34.9 million in Q4 2025, and -$50.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Rocket Pharmaceuticals | 357.93 Mn | 357.93 Mn | - | -45.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.49 Mn |
| Mar 31, 2026 | -45.49 Mn |
| Dec 31, 2025 | -34.92 Mn |
| Dec 31, 2025 | -34.92 Mn |
| Sep 30, 2025 | -50.78 Mn |
| Sep 30, 2025 | -50.78 Mn |
| Jun 30, 2025 | -48.91 Mn |
| Jun 30, 2025 | -48.91 Mn |
| Mar 31, 2025 | -55.84 Mn |
| Mar 31, 2025 | -55.84 Mn |
| Dec 31, 2024 | -52.54 Mn |
| Dec 31, 2024 | -52.54 Mn |
| Sep 30, 2024 | -48.40 Mn |
| Sep 30, 2024 | -48.40 Mn |
| Jun 30, 2024 | -55.75 Mn |
| Jun 30, 2024 | -55.75 Mn |
| Mar 31, 2024 | -58.89 Mn |
| Mar 31, 2024 | -58.89 Mn |
| Dec 31, 2023 | -44.11 Mn |
| Dec 31, 2023 | -44.11 Mn |